Moderna
Corporate Bias Rating
Expand Summary
Risk Level:
Summary:
Moderna is High Risk. The company yields to political activism in shaping corporate governance, potentially alienating consumers, dividing employees, and harming shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. Moderna embraces corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach fails to safeguard free exercise, free speech, and free enterprise.
View Full Corporate Bias Ratings ReportBoard Bias
Expand Summary
CEO of Moderna
Stephane Bancel
Summary:
Headquartered in Cambridge, Massachusetts, Moderna is a member of the Fortune 250 operating in the Pharmaceuticals Biotechnology and Life Sciences industry. Stephane Bancel and Noubar Afeyan serve as CEO/President and Chairman, respectively, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $12,350 to Republican causes and $1,391,741 to Democratic causes. Under their tenure, Moderna currently holds a 'High Risk' risk rating.
View Full Board Bias ReportPolitical Contributions of Leadership:
$12,350
$1,391,741
Republican
Democrat